Brandolini, Laura
Grannonico, Marta
Bianchini, Gianluca
Colanardi, Alessia
Sebastiani, Pierluigi
Paladini, Antonella
Piroli, Alba
Allegretti, Marcello
Varrassi, Giustino
Di Loreto, Silvia http://orcid.org/0000-0002-8256-5819
Funding for this research was provided by:
Fondazione P. Procacci (Prot.n. 1938)
Dompè Farmaceutici SpA (MTA 06/2016)
Article History
Received: 4 December 2018
Revised: 14 March 2019
Accepted: 15 March 2019
First Online: 5 April 2019
Change Date: 6 May 2019
Change Type: Correction
Change Details: The article The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury, written by Laura Brandolini, Marta Grannonico, Gianluca Bianchini, Alessia Colanardi, Pierluigi Sebastiani, Antonella Paladini, Alba Piroli, Marcello Allegretti, and Giustino Varrassi.
Compliance with Ethical Standards
:
: Laura Brandolini, Gianluca Bianchini, and Marcello Allegretti are employees of Dompé Farmaceutici SpA, Italy. The company has interests in the development of C5aR antagonists for the treatment of pain conditions. The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice where the studies were conducted.